SCHEMBL3845667

SCHEMBL3845667

Fc1cccc(F)c1-c1nn(C(c2ccccc2)(c2ccccc2)c2ccccc2)cc1-c1ccc2ncc(-c3noc(C4CC4)n3)n2c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIT P10721 5/20 0.36
CNR2 P34972 1/20 0.35
TGFBR1 P36897 3/20 0.33
PIK3CA P42336 2/20 0.33
PIK3CB P42338 1/20 0.33
MTOR P42345 1/20 0.33
CDK19 Q9BWU1 1/20 0.33
LMNA P02545 2/20 0.32
MEN1 O00255 1/20 0.32
MAPT P10636 1/20 0.32
HTT P42858 1/20 0.32
RECQL P46063 1/20 0.32
KMT2A Q03164 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
ALOX15 P16050 1/20 0.32
TSHR P16473 1/20 0.32
MAPK1 P28482 1/20 0.32
DGAT1 O75907 1/20 0.32
POLB P06746 1/20 0.32
GABRA1 P14867 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3846554 0.94 CNR2 (0.39) KITCNR2TGFBR1PIK3CAPIK3CB
SCHEMBL3847074 0.90 LMNA (0.38) KITCNR2TGFBR1PIK3CAPIK3CB
SCHEMBL3854699 0.89 MAPK14 (0.40) KITCNR2TGFBR1PIK3CAPIK3CB
SCHEMBL3847653 0.88 KIT (0.36) KITCNR2TGFBR1PIK3CAPIK3CB
SCHEMBL3846800 0.88 CNR2 (0.39) KITCNR2PIK3CAPIK3CBMTOR
SCHEMBL3845668 0.86 KIT (0.32) KITCNR2PIK3CAPIK3CBMTOR
SCHEMBL3852556 0.86 TGFBR1 (0.34) TGFBR1PIK3CAPIK3CBMTORCDK19
SCHEMBL3845896 0.86 TP53 (0.37) KITPIK3CAPIK3CBMTORCDK19
SCHEMBL3847453 0.86 TGFBR1 (0.35) TGFBR1PIK3CAPIK3CBMTORCDK19
SCHEMBL3847664 0.85 NPC1 (0.34) TGFBR1PIK3CAPIK3CBMTORCDK19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed